Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017
News Industry News Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat